KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Equity Average (2019 - 2026)

Hims & Hers Health's Equity Average history spans 8 years, with the latest figure at $493.5 million for Q1 2026.

  • On a quarterly basis, Equity Average fell 3.79% to $493.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $493.5 million, a 3.79% decrease, with the full-year FY2025 number at $508.8 million, up 23.99% from a year prior.
  • Equity Average hit $493.5 million in Q1 2026 for Hims & Hers Health, down from $561.0 million in the prior quarter.
  • Over the last five years, Equity Average for HIMS hit a ceiling of $571.8 million in Q3 2025 and a floor of $311.3 million in Q4 2022.
  • Historically, Equity Average has averaged $401.3 million across 5 years, with a median of $344.3 million in 2024.
  • The widest YoY moves for Equity Average: up 354.92% in 2022, down 9.73% in 2022.
  • Tracing HIMS's Equity Average over 5 years: stood at $311.3 million in 2022, then grew by 8.01% to $336.3 million in 2023, then soared by 36.3% to $458.4 million in 2024, then grew by 22.38% to $561.0 million in 2025, then decreased by 12.02% to $493.5 million in 2026.
  • Business Quant data shows Equity Average for HIMS at $493.5 million in Q1 2026, $561.0 million in Q4 2025, and $571.8 million in Q3 2025.